|
You are here: Home: Meet The Professors Vol. 3 Issue 2 2005: Faculty Disclosures
 |
Howard A
Burris III, MD
Director of Drug
Development
Sarah Cannon
Research Institute
Nashville, Tennessee |
 |
Nancy E
Davidson, MD
Professor of Oncology
Breast Cancer Research
Chair in Oncology
Director of the Breast
Cancer Research
Program, The Sidney
Kimmel Comprehensive
Cancer Center at
Johns Hopkins
Baltimore, Maryland |
 |
Kathy D
Miller, MD
Sheila D Ward
Scholar of Medicine
Assistant Professor
of Medicine
Department of
Hematology/Oncology
Indiana University
School of Medicine
Indianapolis, Indiana |
 |
Mark D
Pegram, MD
Associate Professor
of Medicine
David Geffen School of
Medicine at UCLA
Director, Women’s
Cancer Program, UCLA/
Jonsson Comprehensive
Cancer Center
Los Angeles, California |
Arnold S Blaustein, MD
Miami Beach, Florida
David M Dresdner, MD
St Petersburg, Florida
Lucio Gordan, MD
Gainesville, Florida
Lowell L Hart, MD
Fort Myers, Florida |
Elisa Krill-Jackson, MD
Miami Beach, Florida
Rosemary Lambert-Falls, MD
Columbia, South Carolina
Susan L Luedke, MD
St Louis, Missouri
Leonard J Seigel, MD
Fort Lauderdale, Florida |
Lawrence A Tepper, DO
West Palm Beach, Florida
James K Weick, MD
Lake Worth, Florida
Michael S Wertheim, MD
Port Saint Lucie, Florida
Richard S Zelkowitz, MD
Norwalk, Connecticut |
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
Dr Burris — Grants/Research Support: Amgen Inc, Bristol-Myers Squibb Company, Cell Therapeutics Inc, Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals, Pfizer Inc, Roche Laboratories Inc; Honorarium: Bristol-Myers Squibb Company, Genentech BioOncology, Sanofi- Aventis. Dr Davidson — Consultant and Honorarium: AstraZeneca Pharmaceuticals LP; Speakers Bureau: Eli Lilly and Company. Dr Miller — Grants/Research Support: GlaxoSmithKline, Medarex Inc, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Pegram — Consultant: Amgen Inc, Genentech BioOncology, Roche Laboratories Inc.
|
|
